COVID-19

For the study, the research team modeled COVID-19 transmission rates and the optimal allocation of an initially limited vaccine supply in the United States under a variety of scenarios.

Two-thirds of surveyed physicians said patients are presenting with more late-stage cancers, with 73% saying patients in their practice are not receiving screenings.

Hager Hanon, PharmD, RPh, senior pharmacist at Community Care Rx, discusses COVID-19 vaccination hesitancy among pregnant women and people with a history of anaphylaxis.

Further, the findings indicate that rapid screens can predict infection with nearly the same precision as antibody tests conducted in a lab, which could be useful for providers.

After the implementation of measures to stop COVID-19, newly detected respiratory viruses were approximately 80% lower compared to the same time period from 2015 to 2019.

Modifications include high rates of neoadjuvant endocrine chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.

After reviewing the mechanisms of the first three COVID-19 vaccines granted emergency use authorization, we can now address some of the most common concerns that have been expressed regarding vaccine hesitancy.

Ted Karkus, CEO of ProPhase Labs, discusses the differences between saliva COVID-19 tests and nasal swab COVID-19 tests and their different uses in clinical practice.

While the prevalence of COVID-19 in patients with COPD is relatively low, those who are infected with the virus experience more severe symptoms than those without COPD.

Opioid overdoses are killing nearly as many of our neighbors and patients as COVID-19 and in much younger populations.

The Pfizer and BioNTech vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 variant is prevalent.

In April 2020, colonoscopy screenings declined from 15.1 per 10,000 beneficiaries to 0.9, a 95% difference.

Patients who received a flu shot during the last flu season were significantly less likely to test positive for a COVID-19 infection at the start of the pandemic, according to a study published in the American Journal of Infection Control.

Pharmacist-led services are not only important during COVID-19 immunization efforts in the United States, but are additionally critical in vaccination endeavors globally.

Thoughtful application can reduce resistance and improve overall operations, if consistent steps are followed.

Aspects of normal life outside of the pandemic could create difficulties for children with type 1 diabetes, including pressures around food in school.

The team discovered a correlation between the implementation of Henry Ford’s universal mask policy and a significant drop in the rate at which its health care workers tested positive for SARS-CoV-2.

Earlier research has found that vitamin D supplementation can prevent inflammation in other respiratory diseases, but there have been limited studies examining the role of vitamin D supplementation in COVID-19.

The results from a phase 3 trial in a population of American adolescents aged 12 to 15 years found that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 showed 100% efficacy and robust antibody responses.

The Biden administration has moved to activate 40,000 local pharmacies within the Federal Retail Pharmacy Program, which is a part of the administration’s national COVID-19 vaccination strategy.

The APhA and the CDC announced that they have entered into a collaborative agreement focused on supporting the role of pharmacists in building the public’s confidence in COVID-19 vaccines.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Daily national surveys by Carnegie Mellon University (CMU) show that although COVID-19 vaccine uptake has increased, the proportion of vaccine-hesitant adults has remained unchanged.

The pharmacy community has stepped up mightily to ensure this massive health care effort is successful.

A prognostic COVID-19 Severity Test has been launched for the identification of high-risk individuals who are likely to experience the most severe COVID-19 complications upon exposure to the virus.